Brief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
04/06/2024 06:02
June 4 (Reuters) - Double Bond Pharmaceutical
International AB (publ) DBPHAb.TE :
* DBP INTERNATIONAL AB AND VIVO BIOPHARMA LLC: REVISED ASSET
PURCHASE AND COLLABORATION AGREEMENTS
* DBP WILL CONTINUE TO COLLABORATE WITH VIVO TO ADVANCE
SI-053
PROGRAM
* DOUBLE BOND PHARMACEUTICAL INTERNATIONAL - DBP IS ENTITLED
TO
RECEIVE MORE THAN $150 MILLION OF MILESTONE AND ROYALTY PAYMENTS
FROM VIVO.
* DOUBLE BOND PHARMACEUTICAL INTERNATIONAL - DBP IS ENTITLED
TO
RECEIVE MORE THAN $150 MILLION OF MILESTONE AND ROYALTY PAYMENTS
FROM VIVO
Source text for Eikon: ID:nWkr1vVbJl
Further company coverage: DBPHAb.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University